Gastrointestinal adverse effects such as nausea, vomiting, ileus, and gastroparesis may be responsible for non-adherence to treatment in the long term
[1] Patients considering any modification to standard dosing regimens should discuss this thoroughly with their GP or endocrinologist, as unsupervised dose adjustments may compromise treatment effectiveness and safety
the STEP 5 trial showed sustained 15.2% weight loss at 2 years Starting Retatrutide (Based on Clinical Trial Protocols) Weeks 1-4: Low starting dose
Manufacturers often adjust dose or add protective coatings to boost absorption in drop formulations
N-acetylcysteine (NAC) Among inositol alternatives for PCOS, NAC has one of the more established clinical records
For example, high-dose biotin supplementation can interfere with certain lab tests used to monitor peptide therapy